| A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (NCT05346484) | Imugene Limited | 2022-05-17 |
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer (NCT05054374) | Memorial Sloan Kettering Cancer Center | 2021-09-14 |
| Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19 (NCT04747249) | Centre Francois Baclesse | 2021-06-18 |
| Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies (NCT04552288) | Memorial Sloan Kettering Cancer Center | 2020-09-16 |
| An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors (NCT04443088) | Shenzhen Ionova Life Sciences Co., Ltd. | 2020-06-26 |
| Geriatric Oncology Screening of Older Patients With Solid Cancers (NCT04644874) | Odense University Hospital | 2020-06-03 |
| A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma (NCT04200963) | Ikena Oncology | 2019-12-18 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor (NCT03590808) | Seoul National University Hospital | 2018-09-01 |
| Oral AMXT 1501 Dicaprate in Combination With DFMO (NCT03536728) | Aminex Therapeutics, Inc. | 2018-06-12 |
| Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology (NCT04264975) | Asan Medical Center | 2018-06-04 |
| Prevention of Chest Pain in Chemo-treated Cancer Patients (NCT03486340) | Vejle Hospital | 2018-04-11 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (NCT03129139) | Minneamrita Therapeutics LLC | 2017-10-10 |
| PEN-866 in Patients With Advanced Solid Malignancies (NCT03221400) | Tarveda Therapeutics | 2017-08-29 |
| A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) (NCT02974738) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-12-07 |
| Study of Blood Immune Cells in Cancer Patients Compared to Controls (NCT01312701) | Hadassah Medical Organization | 2011-03-01 |